Prot # 104-201102: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere's Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date9/26/11 → 9/14/15

Funding

  • Rho, Inc (Prot # 104-201102 // Prot # 104-201102)
  • Otonomy, Inc. (Prot # 104-201102 // Prot # 104-201102)